期刊文献+

山西汉族可溶性HLA-Ⅰ类抗原检测 被引量:1

Detection of serum-soluble HLA class Ⅰ antigens in the population of the Han nationality in Shanxi province
下载PDF
导出
摘要 目的:定量检测正常人血清中可溶性人白细胞抗原-Ⅰ(sHLA-Ⅰ),以探讨山西汉族人群的正常参考值。方法:ELISA法检测血清sHLA-Ⅰ类抗原水平。将不同浓度的标准品和待检血清分别加入包被有特异性sHLA-Ⅰ抗体的酶标板,与生物素化的sHLA-Ⅰ、辣根过氧化物酶(HRP)标记的链霉亲和素共同孵育,弃上清并用洗涤液洗涤,加底物应用液四甲基联苯胺(TMB)显色,以酶标仪450nm测定吸光度值,根据不同浓度标准品显色后测得的吸光度值绘制标准曲线,测定60例健康山西人的sHLA-Ⅰ含量。结果:ELISA法能够准确检测sHLA-Ⅰ含量,60例健康山西人的sHLA-Ⅰ含量为(382.62±106.68)ng.ml-1。结论:山西汉族人群sHLA-Ⅰ正常值为(382.62±106.68)ng.ml-1。 Objective: To evaluate the reference value of soluble human leukocyte antigen class I (sHLA- I ) in the population of the Han nationality in Shanxi province. Methods: Enzyme-linked immunosorbent assay(ELISA) was used to measure the level of sHLA- I. Microtitration wells were coated with sHLA- I antibody of defined and unique epitope specificity. Standards and corre- sponding samples were added into different mierotitration wells respectively, and then biotinylated sHLA- I and streptavidin labeled with enzyme horseradish peroxidase(HRP) were added into each well. After incubation and washing, a TMB substrate Solution was added to the wells and color developed in proportion to the amount of sHLA- I bound. The intensity of the color was measured at 450nm. Standard curve was obtained by quantification of sHLA- I standard reagent in series dilution, the level of sHLA- I antigens was examined in 60 normal persons. Results: sHLA- I antigens can be exactly quantified by ELISA, and the average concentration ob- tained from 60 normal persons was (382.62,106. 68)ng· ml-1. Condnsions:The level of sHLA- I antigens in normal individuals of the Han nationality in Shanxi province was (382. 62±106. 68) ng· ml-1.
出处 《四川生理科学杂志》 2009年第2期72-74,共3页 Sichuan Journal of Physiological Sciences
基金 山西高校科技研究开发项目(编号20051318)资助 长治医学院基金(编号200404)资助
关键词 可溶性人白细胞抗原-Ⅰ 酶联免疫吸附试验 定量检测 sHLA-I Enzyme-linked immunosorbent assay Quantification
  • 相关文献

参考文献12

  • 1Van Rood JJ, Van Leeuwen A, Van Santen MC. Anti-HLA-A2 inhibitor in normal human serum[J]. Nature, 1970; 226(2): 366- 367.
  • 2Haynes LD, Waldman WJ, Bushkin Y, et al. CMV-infected allogeneic endothelial cells initiate responder and bystander donor HLA class Ⅰ release via the metalloproteinase cleavage pathway[J].Hum Immunol, 2005,66(3): 211-221.
  • 3Irena A, Roger EK, Thomas P, et al. Soluble HLA: patterns of expression in normal subjects, autoimmune diseases, and transplant recipients[J]. Rheumatol Int, 2005,25(3): 491-500.
  • 4Wolf RE, Adamashvili IM, Geled FB, et al. Soluble HLA-Ⅰ in rheumatic diseases[J]. Hum Immunol, 1998, 59(4): 644-649.
  • 5Contini P, Ghio M, Merlo A, et al. Soluble HLA class Ⅰ/CD8 ligation triggers apoptosis in EBV-specific CD8(+) cytotoxic T lymphocytes by Fas/Fas ligand interaction[J]. Hum immunol, 2000, 61 (10):1347-1351.
  • 6Contini P, Zocchi MR, Pierri I, et al. In vivo apoptosis of CD8(+) lymphocytes in acute myeloid leukemia patients: involvement of soluble HLA-Ⅰ and Fas ligand[J]. Leukemia, 2007,21(2): 253-260.
  • 7Shimur T, Hagihara M, Yamamoto K, et al. Quantification of serum soluble HLA class Ⅰ antigens in patients with gastric cancer[J]. Hum Immunol, 1994,40(1):183-192.
  • 8Yang C W, Kim T G, Kim Y S,et al. Serum soluble HLA class Ⅰ antigens levels in hemodialysis patients and following renal transplantation[J]. Am J Nephrol, 1995,15(1):290-294.
  • 9McDonald J, Gelder F, Aultman D, et al. HLA in human serumquantification of class Ⅰ by enzyme immunoassay[J]. Transplantation, 1992,53(2):445-459.
  • 10兰炯采,吴涛,周华友,张印则,魏亚明,赖植发,曹琼,杨全科,武大林,刘忠.可溶性HLA-I检测技术和贮存血中可溶性HLA-I的浓度变化观察[J].中国实验血液学杂志,2004,12(3):363-367. 被引量:7

二级参考文献18

  • 1Ghio M,Contini P,Mazzei C,et al.Soluble HLA class I,HLA class Ⅱ,and Fas ligand in blood components: a possible key to explain the immunomodulatory effects of allogeneic blood transfusions.Blood,1999; 93:1770- 1777
  • 2Pouletty P,Ferrone S,Amesland F,et al.Summary report from the first intemational workshop on soluble HLA antigens.Tissue Antigens,1993; 42:45 - 54
  • 3Grumet FC,Buelow R,Grosse-Wilde H,et al.Report of the second intrenational soluble HLA (sHLA) workshop.Human Immunol,1994; 40:153- 165
  • 4Inostroza J,Munoz P,Espinoza R,et al.Quantitaion of soluble HLA class I heterodimers and beta 2-microglobulin in patients with active pulmonary tuberculosis.Hum Immunol,1994; 40:179 -182
  • 5Shimura T,Hagihara M,Yamamoto K,et al.Quantification of serum- soluble HLA class I antigens in patients with gastric cancer.Hum Immunol,1994; 40:183 - 186
  • 6DeVito-Haynes LD,Jankowska-Gan E,Sollinger HW,et al.Monitoring of kidney and simultaneous pancreas-kidney transplantation rejection by release of donor-specific,soluble HLA class I.Hum Immunol,1994; 40:191 - 201
  • 7Yang CW,Kim TG,Kim YS.Serum soluble HLA class I antigen levels in hemodialysis patients and following renal transplantation.Am J Nephrol,1995; 15:290 - 294
  • 8Ghio M,Contini P,Mazzei C,et al.Soluble HLA class Ⅰ and Fas ligand molecules in blood components and their role in the immunomodulatory effects of blood transfusions.Leuk lymphoma,2000; 39(1-2):29-36
  • 9Puppo F,Contini P,Ghio M,et al.CD8 + Soluble human MHC class Ⅰ molecules induce soluble Fas ligand secretion and trigger apoptosis in activated CD8+ Fas (CD95+ ) T lymphocytes.Int Immunol,2000; 12:195 - 203
  • 10Zavazava N,Bottcher H,Ruchholtz WM.Soluble MHC class Ⅰ antigens (sHLA) and anti-HLA antibodies in heart and kidney allograft recipients.Tissue Antigens,1993; 42:20 - 26

共引文献23

同被引文献8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部